Please assess the completion status of the following clinical trial:

Trial Title: Metabolic and Cardiovascular Effects of Renal Denervation

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Essential hypertension~* Systolic blood pressure \>160 mm Hg despite ≥3 antihypertensive drugs~* Clinical patients accepted for renal denervation~Exclusion Criteria:~* Type 1 diabetes~* Pregnancy~* Glomerular filtration rate ≤45 ml/min/1,73 m2~* Pacemaker/ICD~* Myocardial infarction/stroke the last 12 months

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Single arm (Type: EXPERIMENTAL): 15 clinical patients undergoing renal denervation

Based on this trial design, predict the completion outcome and termination type (if applicable).